Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

Stock Recap
#PipelineProspector

CHLORPHENIRAMINE POLISTIREX

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

16 API Suppliers, 5 USDMF, 1 CEP/COS, 4 EU WC, 3 KDMF, 3 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

8 Drugs in Development

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

27 FDF Dossiers, 14 FDA Orange Book, 7 Europe, 3 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML, SYRUP;ORAL - 2MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 3 SPI Pharma, 4 DKSH, 2 Pharm-RX Chemical, 7 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 3 Kirsch Pharma, 6 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 7 BASF, 1 Bioplus Life Sciences, 2 CD Formulation, 4 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 11 Kerry, 1 Keval Exports, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 18 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Silverline Chemicals, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

38 Fillers, Diluents & Binders, 21 Thickeners and Stabilizers, 20 Direct Compression, 16 Disintegrants & Superdisintegrants, 16 Granulation, 14 Film Formers & Plasticizers, 13 Taste Masking, 11 Lubricants & Glidants, 11 Parenteral, 11 Co-Processed Excipients, 9 Chewable & Orodispersible Aids, 9 Coating Systems & Additives, 7 Topical, 6 Solubilizers, 6 Controlled & Modified Release, 4 Rheology Modifiers, 4 Emulsifying Agents, 3 API Stability Enhancers, 1 Soft Gelatin

DIGITAL CONTENT

4 News #PharmaBuzz

4 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

2 US Medicaid Prescriptions

MARKET PLACE

7 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
29/11/2025	Supriya Lifescience	India	IMCD Korea Co., Ltd.	20210302-211-J-852(2)	Dexchlorpheniramine maleate	2024-09-11	Supriya Lifescience Ltd.	India	A-5/2, Lote Parshuram Industrial Area, MIDC Tal-Khed. Dist-Ratnagiri, Maharashtra, Pin-415 722, India
29/11/2025	Supriya Lifescience	India	Daeshin Pharmaceutical Co., Ltd.	20210302-211-J-852(1)	Dexchlorpheniramine maleate	2021-12-06	Supriya Lifescience Ltd.	India	A-5/2, Lote Parshuram Industrial Area, MIDC Tal-Khed. Dist-Ratnagiri, Maharashtra, Pin-415 722, India

CHLORPHENIRAMINE POLISTIREX

CHLORPHENIRAMINE POLISTIREX

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

16 API Suppliers

5 USDMF

1 CEP/COS

4 EU WC

3 KDMF

3 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

FINISHED DOSAGE FORMULATIONS

27 FDF Dossiers

14 FDA Orange Book

7 Europe

3 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML

SYRUP;ORAL - 2MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

3 SPI Pharma

4 DKSH

2 Pharm-RX Chemical

7 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

3 Kirsch Pharma

6 Actylis

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

7 BASF

1 Bioplus Life Sciences

2 CD Formulation

4 DFE Pharma

1 Finar

7 Gangwal Chemicals

1 Ideal Cures

11 Kerry

1 Keval Exports

10 Microlex e.U

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

2 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

18 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

2 Silverline Chemicals

2 Ulanqab Kema New Material

1 Valens Pharmachem

2 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

38 Fillers, Diluents & Binders

21 Thickeners and Stabilizers

20 Direct Compression

16 Disintegrants & Superdisintegrants

16 Granulation

14 Film Formers & Plasticizers

13 Taste Masking

11 Lubricants & Glidants

11 Parenteral

11 Co-Processed Excipients

9 Chewable & Orodispersible Aids

9 Coating Systems & Additives

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons